JavaScript has been disabled within your browser, the content or the functionality of this web page can be limited or unavailable.

As flu activity continues to rise, FirstHealth is reinforcing visitor guidelines and encouraging preventive measures to protect patients, visitors and care teams. Visitor restrictions are in place at all FirstHealth facilities.

Main Navigation

Find a Provider

Use the provider search to find providers throughout our health care network.

View All Providers

Popular Specialty Searches

Search for a Doctor

Advanced Search Options View FirstHealth Physician Group Providers Only

Medical Care

We provide expertise in all major medical and surgical specialties and numerous sub-specialties.

View All Services

Popular Searches

Search our A to Z List of Medical Services

Hospitals & Locations

Use the location search to find locations throughout our health care network.

View All Locations

Hospitals

Location Types

Search for a Location

Patients & Visitors

Learn More

Volunteer at FirstHealth

Patients & Family Services

Visitor Information

Wellness & Fitness

Explore classes and events designed to improve your health and wellbeing.

Learn More

FirstHealth News

Popular Searches

Health Classes & Events

View All Classes & Events

Fitness Classes

View All Fitness Classes

Site Search

Search for providers, medical specialties or locations.

FirstHealth News

How can we help you?

Sub Heading

Clinical Trials Details

Back to Results

A Randomized Phase III Trial of Olanzapine Versus Megestrol Acetate for Cancer-Associated Anorexia

IRB Protocol Number

A222004

Clinical Trial Categories

Solid Tumors

How to Participate

Eligibility:

Adults 18 years of age or older with advanced cancer, without previous or current use of Olanzapine and have a poor appetite and a 5 pound weight loss over 2 months.

Contact Us

For more information on participating in a clinical trial, contact us at 910-715-2200 or talk to your doctor.